Reduced YB-1 expression, in turn, caused a marked decrease in both the size (Fig. 2B and Appendix Fig. S3C, D) and YB-1 content (Appendix Fig. S3E) of the tumours produced from the transduced cells at their SQ sites of injection. Here, YBX1 is linked to neoplasm.